Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

MedAssets Inc signs definitive agreement to acquire Sg2


Wednesday, 13 Aug 2014 08:00am EDT 

MedAssets Inc:Signs definitive agreement to acquire privately held SG-2, LLC (Sg2).Says for about $142 mln.Under terms of agreement, MedAssets will acquire Sg2 for about $142 mln to be funded with cash on hand and borrowings under existing credit facility.Sg2 financial results and additional terms of the transaction were not disclosed.Transaction is subject to customary closing conditions and regulatory approvals, and is expected to be completed within 60 to 90 days.Deutsche Bank Securities Inc., is acting as the exclusive financial advisor to MedAssets in this transaction, and Willkie Farr & Gallagher LLP is acting as company's legal counsel.Marwood Group acted as market research advisor during due diligence for the transaction. Robert W. Baird is acting as financial advisor to Sg2 in the transaction, and Freeborn & Peters is acting as legal counsel. 

Company Quote

19.85
-0.11 -0.55%
26 Dec 2014